These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34258611)

  • 1. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
    Alagoz O; Lowry KP; Kurian AW; Mandelblatt JS; Ergun MA; Huang H; Lee SJ; Schechter CB; Tosteson ANA; Miglioretti DL; Trentham-Dietz A; Nyante SJ; Kerlikowske K; Sprague BL; Stout NK;
    J Natl Cancer Inst; 2021 Nov; 113(11):1484-1494. PubMed ID: 34258611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
    Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
    J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
    Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
    Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of telemedicine to maintain breast cancer follow-up and surveillance during the COVID-19 pandemic.
    Sonagli M; Cagnacci Neto R; Leite FPM; Makdissi FBA
    J Surg Oncol; 2021 Feb; 123(2):371-374. PubMed ID: 33333581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COVID-19 BreastScreen Department - beyond the pandemic.
    Spuur KM
    J Med Radiat Sci; 2020 Dec; 67(4):352-355. PubMed ID: 33026711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
    Plevritis SK; Munoz D; Kurian AW; Stout NK; Alagoz O; Near AM; Lee SJ; van den Broek JJ; Huang X; Schechter CB; Sprague BL; Song J; de Koning HJ; Trentham-Dietz A; van Ravesteyn NT; Gangnon R; Chandler Y; Li Y; Xu C; Ergun MA; Huang H; Berry DA; Mandelblatt JS
    JAMA; 2018 Jan; 319(2):154-164. PubMed ID: 29318276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the Covid-19 pandemic on breast cancer early detection and screening.
    ; Figueroa JD; Gray E; Pashayan N; Deandrea S; Karch A; Vale DB; Elder K; Procopio P; van Ravesteyn NT; Mutabi M; Canfell K; Nickson C
    Prev Med; 2021 Oct; 151():106585. PubMed ID: 34217412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    Johnson KJ; O'Connell CP; Waken RJ; Barnes JM
    PLoS One; 2024; 19(5):e0303280. PubMed ID: 38768115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
    Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
    CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
    van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Cevik M; Schechter CB; Lee SJ; Huang H; Li Y; Munoz DF; Plevritis SK; de Koning HJ; Stout NK; van Ballegooijen M
    Med Decis Making; 2018 Apr; 38(1_suppl):112S-125S. PubMed ID: 29554471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.
    Birnbaum J; Gadi VK; Markowitz E; Etzioni R
    Ann Intern Med; 2016 Feb; 164(4):236-43. PubMed ID: 26756332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
    Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
    Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer statistics, 2011.
    DeSantis C; Siegel R; Bandi P; Jemal A
    CA Cancer J Clin; 2011; 61(6):409-18. PubMed ID: 21969133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer deaths averted over 3 decades.
    Hendrick RE; Baker JA; Helvie MA
    Cancer; 2019 May; 125(9):1482-1488. PubMed ID: 30740647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
    Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
    Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.